Publications by authors named "Philip Maclaughlin"

Claim this Profile
I
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities.
Carling J Ursem, Naomi L Kruhlak, Joseph F Contrera, Philip M MacLaughlin, R Daniel Benz

Regul Toxicol Pharmacol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QSAR modeling of carcinogenic risk using discriminant analysis and topological molecular descriptors.
Joseph F Contrera, Philip Maclaughlin, Lowell H Hall, Lemont B Kier

Curr Drug Discov Technol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis